Biotechnology has long relied on a handful of model microorganisms, such as Escherichia coli and Saccharomyces cerevisiae, whose genetics and physiology are ...
Fintel reports that on August 15, 2023, Morgan Stanley maintained coverage of IO Biotech (NASDAQ:IOBT) with a Overweight recommendation. As of August 2, 2023, the average one-year price target for IO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results